摘要
目的:观察环磷腺苷葡胺与甲氧吡酮(米力农)治疗老年人心力衰竭的疗效。方法:将80例老年充血性心力衰竭患者分为2组。环磷腺苷葡胺组(n=40)、米力农组(n=40)。环磷腺苷葡胺组:先给环磷腺苷葡胺30mg加5%葡萄糖20mL缓慢静脉推注,再给150mg加5%葡萄糖250 mL静脉滴入,每日1次,连用7 d。米力农组:甲氧吡酮2.5 mg口服,每日4次,连用7 d。结果:2组患者总有效率分别为87.5%、82.5%。2组疗效比较无显著差异(P<0.05)。结论:环磷腺苷葡胺是治疗老年人充血性心力衰竭安全有效的药物。
Objective: To study the clinical effects of treating congestive heart failure with Meglumine Cyclic Adenosine vs Milrinone. Methods: 80 inpatients with congestive heart failure were randomly divided into two groups. (1) meglumine cyclic adenosme (40 cases), (2) milrinone (40 cases). Patients in first group received MCA (30 mg) in 5% glucose 20 ml via intravenous injection, then MCA (150 mg) + 5% glucose 250 ml was injected intravenously once a day. The second group received milrinone 2. 5 mg four times each day. Results: After one week's treatment, the total clinical effective rates for each group were 87. 5% and 82. 5% respectively, while the difference in the two groups was not significant (P>0. 05). Conclusion: MCA is an effective medicine in treatment of elderly congestive heart failure.
出处
《中国临床医学》
北大核心
2005年第1期21-22,共2页
Chinese Journal of Clinical Medicine
